US Patent Issued to GT GAIN THERAPEUTICS on June 23 for "Heteroaryl compounds and therapeutic uses thereof in conditions associated with the alteration of the activity of beta-glucocerebrosidase" (Spanish, Swiss Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,342, issued on June 23, was assigned to GT GAIN THERAPEUTICS SA (Lugano, Switzerland).

"Heteroaryl compounds and therapeutic uses thereof in conditions associated with the alteration of the activity of beta-glucocerebrosidase" was invented by Ana Maria Garcia Collazo (Esplugues de Llobregat, Spain), Elena Cubero Jorda (Barcelona, Spain), Manolo Bellotto (Lugano, Switzerland) and Enrique Fernandez Inglesias (Hospitalet de Llobregat, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The application is directed to compounds of formulae (IA) and (IB) and their salts and solvates, wherein R1a, R2a, R3a, A1, A2, A3, R1b, R2b, R3b, B1, and B2 are as set...